The new political economy of pharmaceuticals : production, innnovation and TRIPS in the global south

ed. by Hans Löfgren ...

"Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. TRIPS is widely considered to have had a negative impact on access to medicines through its rules on pharmaceutical patents. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs and assesses the wider political economy of drug production and consumption in the Global South"--

MoreLess

Year of publication:	2013
Other Persons:	Löfgren, Hans (contributor)
Publisher:	Basingstoke, Hampshire [u.a.] : Palgrave Macmillan
Subject:	Pharmaindustrie \| Pharmaceutical industry \| Arzneimittel \| Pharmaceuticals \| Pharmakologie \| Pharmacology \| Patentrecht \| Patent law \| Arzneimittelmarkt \| Pharmaceutical market \| Immaterialgüterrechte \| Intellectual property rights \| TRIPS \| Gesundheitspolitik \| Health policy \| Gesundheitsversorgung \| Health care \| Entwicklungsländer \| Developing countries \| Übereinkommen über handelsbezogene Aspekte der Rechte an geistigem Eigentum <1994 April 15> \| Gewerblicher Rechtsschutz
Description of contents:	Table of Contents [gbv.de] ; Description [netread.com]

Check Google Scholar |

More access options

In libraries world-wide (WorldCat)

In German libraries (KVK)

subito order

I need help

Extent:	XVI, 265 S. graph. Darst. cm
Series:	Intrernational political economy series
Type of publication:	Book / Working Paper
Type of publication (narrower categories):	Sammelwerk ; Collection of articles of several authors ; Fallstudie ; Case study
Language:	English
Notes:	Enth. 13 Beitr. Literaturangaben Machine generated contents note:1. The New Political Economy of Pharmaceuticals: Conformity and Resistance in the Global South; Owain David Williams and Hans Löfgren -- 2. The Political Economy of Pharmaceutical Production in Brazil; Cassandra M. Sweet -- 3. Pharmaceuticals, Health Policy and Intellectual Property Rights in China; Chee-Ruey Hsieh -- 4. Immunity to TRIPS? Vaccine Production and the Biotechnology Industry in Cuba; Jens Plahte and Simon Reid-Henry -- 5. TRIPS and Access to Medicines in Egypt; Dina Iskander -- 6. The Pharmaceutical Industry in India after TRIPS; Sudip Chaudhuri -- 7. The Health Care System and the Pharmaceutical Industry in Indonesia; Richard Husada and Raymond R. Tjandrawinata -- 8. TRIPS, Free Trade Agreements and the Pharmaceutical Industry in Malaysia; Mohamed Azmi Hassali, Jayabalan Thambyappa, Shankaran Nambiar and Asrul Akmal Shafie -- 9. The Pharmaceutical Industry, Intellectual Property Rights and Access to Medicines in Pakistan: Zaheer-Ud-Din Babar, Shazia Jamshed, Ashar Malik and Anwarul-Hassan Gilani -- 10. TRIPS, Access to Medicines and Local Production in South Africa; Andrew L. Gray and Yousuf A. Vawda -- 11. TRIPS and New Challenges for the Pharmaceutical Sector in South Korea; Bong-min Yang and Hye-young Kwon -- 12. Intellectual Property Rights and Neoliberal Restructuring in Turkey: The Pharmaceutical Industry; Ipek Eren Vural -- 13. Conclusion: TRIPS, Drug Production in the Global South, and Access to Medicines; Hans Löfgren and Owain David Williams. Machine generated contents note: -- 1. The New Political Economy of Pharmaceuticals: Conformity and Resistance in the Global South; Owain David Williams and Hans Löfgren -- 2. The Political Economy of Pharmaceutical Production in Brazil; Cassandra M. Sweet -- 3. Pharmaceuticals, Health Policy and Intellectual Property Rights in China; Chee-Ruey Hsieh -- 4. Immunity to TRIPS? Vaccine Production and the Biotechnology Industry in Cuba; Jens Plahte and Simon Reid-Henry -- 5. TRIPS and Access to Medicines in Egypt; Dina Iskander -- 6. The Pharmaceutical Industry in India after TRIPS; Sudip Chaudhuri -- 7. The Health Care System and the Pharmaceutical Industry in Indonesia; Richard Husada and Raymond R. Tjandrawinata -- 8. TRIPS, Free Trade Agreements and the Pharmaceutical Industry in Malaysia; Mohamed Azmi Hassali, Jayabalan Thambyappa, Shankaran Nambiar and Asrul Akmal Shafie -- 9. The Pharmaceutical Industry, Intellectual Property Rights and Access to Medicines in Pakistan: Zaheer-Ud-Din Babar, Shazia Jamshed, Ashar Malik and Anwarul-Hassan Gilani -- 10. TRIPS, Access to Medicines and Local Production in South Africa; Andrew L. Gray and Yousuf A. Vawda -- 11. TRIPS and New Challenges for the Pharmaceutical Sector in South Korea; Bong-min Yang and Hye-young Kwon -- 12. Intellectual Property Rights and Neoliberal Restructuring in Turkey: The Pharmaceutical Industry; Ipek Eren Vural -- 13. Conclusion: TRIPS, Drug Production in the Global South, and Access to Medicines; Hans Löfgren and Owain David Williams.
ISBN:	0-230-28463-9 ; 978-0-230-28463-0
Classification:	Pharmazie, Pharmazeutika ; Gesundheitsökonomie ; Patentwesen, Erfindungen ; Gewerblicher Rechtsschutz, Verlagsrecht
Source:	ECONIS - Online Catalogue of the ZBW

Persistent link: https://www.econbiz.de/10009793209